← SynDRA
DAPORINAD
SynDRA canonical compound SYN0020187 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | NAMPT | PARP1 |
| Mechanism of action | niacinamide phosphoribosyltransferase inhibitor |
All known targets
Mechanisms of action (all sources)
- NAMPT INHIBITOR
- Nicotinamide phosphoribosyltransferase inhibitor
- niacinamide phosphoribosyltransferase inhibitor
Cross-references
Synonyms
- (E)-DAPORINAD
- (E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE
- 2016-06-07: APO-866
- APO-866
- APO866
- APO866(E)-DAPORINAD
- DAPORINAD(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE
- FK-866
- FK866
- K 22.175
- WK-175
- FK 866
- APO 866
- Daporinad [INN]
- V71TF6V9M7
- DAPORINAD [WHO-DD]
- NSC 751605
- daporinadum
- RefChem:585187
- NMPRTase Inhibitor APO866
- DTXCID401510305
- (E)-Daporinad
- C24H29N3O2
- MFCD10565943
- FK-866 HCl
- 2gvj
- Daporinad (APO866)
- UNII-V71TF6V9M7
- FK866 hydrochloride hydrate
- DGB
- 4o1b
- 4o1d
- SCHEMBL156944
- GTPL7745
- orb1305223
- SCHEMBL29635857
- BDBM81395
- CHEBI:94671
- Daporinad(FK866,APO866)?
Look up DAPORINAD in the interactive SynDRA portal →